Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: None declared.
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.
References
1. Kurihara T, Yanagida A, Yokoi H, Koyata A, Matsuya T, Ogawa J, et al. Evaluation of cardiac assays on a benchtop chemiluminescent enzyme immunoassay analyzer, PATHFAST. Anal Biochem 2008;375:144–6.10.1016/j.ab.2007.12.030Search in Google Scholar PubMed
2. Okamura Y, Yokoi H. Development of a point-of-care assay system for measurement of presepsin (sCD14-ST). Clin Chim Acta 2011;412:2157–61.10.1016/j.cca.2011.07.024Search in Google Scholar PubMed
3. Endo S, Suzuki Y, Takahashi G, Shozushima T, Ishikura H, Murai A, et al. Usefulness of presepsin in the diagnosis of sepsis in a multicenter prospective study. J Infect Chemother 2012;18:891–7.10.1007/s10156-012-0435-2Search in Google Scholar PubMed
4. Kotani K, Minami T, Abe T, Sato J, Taniguchi N, Yamada T. Development of a new point-of-care testing system for measuring white blood cell and C-reactive protein levels in whole blood samples. Clin Chim Acta 2014;433:145–9.10.1016/j.cca.2014.03.004Search in Google Scholar PubMed
5. Lippi G, Banfi G, Maffulli N. Preanalytical variability: the dark side of the moon in blood doping screening. Eur J Appl Physiol 2010;109:1003–5.10.1007/s00421-010-1437-3Search in Google Scholar PubMed
6. Szecsi PB, Odum L. Error tracking in a clinical biochemistry laboratory. Clin Chem Lab Med 2009;47:1253–7.10.1515/CCLM.2009.272Search in Google Scholar PubMed
7. Shirakawa K, Naitou K, Hirose J, Takahashi T, Furusako S. Presepsin (sCD14-ST): development and evaluation of one-step ELISA with a new standard that is similar to the form of presepsin in septic patients. Clin Chem Lab Med 2011;49:937–9.10.1515/CCLM.2011.145Search in Google Scholar PubMed
8. Kweon OJ, Choi JH, Park SK, Park AJ. Usefulness of presepsin (sCD14 subtype) measurements as a new marker for the diagnosis and prediction of disease severity of sepsis in the Korean population. J Crit Care 2014;29:965–70.10.1016/j.jcrc.2014.06.014Search in Google Scholar PubMed
9. Shozushima T, Takahashi G, Matsumoto N, Kojika M, Okamura Y, Endo S. Usefulness of presepsin (sCD14-ST) measurements as a marker for the diagnosis and severity of sepsis that satisfied diagnostic criteria of systemic inflammatory response syndrome. J Infect Chemother 2011;17:764–9.10.1007/s10156-011-0254-xSearch in Google Scholar PubMed
10. Gaur RL, Pai M, Banaei N. Impact of blood volume, tube shaking, and incubation time on reproducibility of QuantiFERON-TB gold in-tube assay. J Clin Microbiol 2013;51:3521–6.10.1128/JCM.01627-13Search in Google Scholar PubMed PubMed Central
©2016 Walter de Gruyter GmbH, Berlin/Boston
